Clinical Trials Browser

Interventional × lucatumumab × Plasma cell × Clear all

NCT00231166 2018-10-11

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

Phase 1 Completed

Multiple Myeloma